Market Tracker

03/27 6:01pm ET

Galena Biopharma Inc (NASDAQ:GALE)

1.35
Delayed Data
As of Mar 27
 -0.03 / -2.17%
Today’s Change
1.33
Today|||52-Week Range
3.58
-10.60%
Year-to-Date

Today’s Trading

Previous close1.38
Today’s open1.40
Day’s range1.35 - 1.41
Volume3,767,029
Average volume (3 months)2,445,541
Market cap$207.7M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+63.53%
Earnings growth (this year)-2.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+274.71%
P/E ratioNM
Price/Sales19.35
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RPRXRepros Therapeutics ...+0.01+0.12%
MDGNMedgenics Inc+0.17+2.07%
ASMBAssembly Biosciences...-0.43-3.23%
FOMXFoamix Pharmaceutica...-0.17-1.79%
Data as of 4:01pm ET, 03/27/2015

Financials

Next reporting dateMay 18, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$9.3M
Annual profit (last year)-$36.6M
Net profit margin-392.81%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark W. Schwartz
Secretary, CAO, Finance Director &
Controller
Ryan Dunlap
Corporate headquarters
Portland, Oregon

Forecasts